phosphoribosyl-n-formylglycineamide has been researched along with Leukemia L 1210 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| BROCKMAN, RW | 2 |
| CHUMLEY, S | 1 |
| Bennett, LL | 1 |
| Smithers, D | 1 |
| Rose, LM | 1 |
| Adamson, DJ | 1 |
| Beardsley, GP | 1 |
| Moroson, BA | 1 |
| Taylor, EC | 1 |
| Moran, RG | 1 |
3 other studies available for phosphoribosyl-n-formylglycineamide and Leukemia L 1210
| Article | Year |
|---|---|
INHIBITION OF FORMYLGLYCINAMIDE RIBONUCLEOTIDE SYNTHESIS IN NEOPLASTIC CELLS BY PURINES AND ANALOGS.
Topics: Adenine; Animals; Antimetabolites; Antineoplastic Agents; Azaserine; Carcinoma, Squamous Cell; Glyci | 1965 |
Mode of action of 2-amino-6-chloro-1-deazapurine.
Topics: 2-Aminopurine; Adenine; AMP Deaminase; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Cel | 1984 |
A new folate antimetabolite, 5,10-dideaza-5,6,7,8-tetrahydrofolate is a potent inhibitor of de novo purine synthesis.
Topics: Animals; Cell Division; Cell Line; DNA Replication; DNA, Neoplasm; gamma-Glutamyl Hydrolase; Glycine | 1989 |